- Air India to raise Rs 5 bn in short-term loans, to mop up another Rs 61 bn
- Chilli powder thrown at Delhi CM Arvind Kejriwal, cops detain suspect
- France moves to oust Ghosn from Renault, defends alliance with Nissan
- Top Masala Bond seller returns to market after govt relaxes tax norms
- IRDAI's in-principle approval for stake sale in IndiaFirst Life Insurance
- RBI Board to set up a committee to examine its Economic Capital Framework
- Why the govt's initiative to disburse subsidies via DBT could fall flat
- Will not contest Lok Sabha elections in 2019, says Sushma Swaraj
Are multinational pharma firms justified in pricing life savings drugs exhorbitantly?
MNCs claim they spend billions and billions of dollars on research and development to make life saving drugs and that they are forced to charge exhorbitantly high prices in order to stay in business. The flip side of this argument is that such drugs are out of reach for the poor and that profit should not be the sole motive for being in the business of wellness, and that cheaper variants of the drug should be made available to the poor by other companies that have the technology to make them. What is your view? Are the MNCs justified or are they just interested in profits, working as they are in an industry where the consumer -- the patient -- has little choice?